IncellDx said this week that it has hired Christine Meda as chief business officer.
Meda will oversee the expansion of the company's companion diagnostics team and operations. She has previously served as president of Response Genetics, vice president of women's health at Roche Molecular Diagnostics, director of scientific affairs for Schering AG, and business unit manager at Bio-Rad Laboratories.
Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner. Grossman previously was head of global strategy and corporate development at Life Tech, and he also held the same position at Invitrogen. Before that, Grossman held various leadership roles at Applied Biosystems, including as a research scientist and patent attorney, VP of intellectual property, and VP of strategy and business development.